FDA Approves Drug for AFib and Atrial Flutter in Critical Care Settings
The approval is based on clinical studies that demonstrated the IV treatment enables rapid management of the heart rate with minimal reduction of blood pressure.
The approval is based on clinical studies that demonstrated the IV treatment enables rapid management of the heart rate with minimal reduction of blood pressure.
Researchers pinpoint a potential reason behind CPAP machines' failure to lower heart disease risk in obstructive sleep apnea patients.
People diagnosed with coronary heart disease at a younger age had a significantly increased risk of developing dementia later in life, according to a new analysis.
Read MoreA recent analysis sheds new insight into the complex relationship between alcohol consumption and the progression of heart disease.
Read MoreResearchers have found further evidence that patients with severe psoriasis are at higher cardiovascular risk.
Read MoreIntravascular imaging-guided percutaneous coronary intervention is associated with a lower rate of target lesion failure compared with angiography-guided PCI, new research finds.
Read MoreThe hearts of 100 patients with sleep apnea are being monitored in a new trial to help researchers understand why they are more likely to die from heart disease.
Read MoreA Denmark study reveals high NSAID use in new myocardial infarction or heart failure patients, prompting calls for concern.
Read MoreA study highlights the significance of cardiac magnetic resonance imaging (CMR) in patients with ventricular arrhythmias. Find out how CMR aids in diagnosis, alters treatment strategies, and predicts major adverse cardiac events, providing crucial insights for improved patient care.
Read More